Ixazomib citrate,
1239908-20-3,
Ixazomib citrate (Ester),
UNII-46CWK97Z3K,
Ixazomib citrate [USAN],
46CWK97Z3K,
Ixazomib citrate (USAN),
1,3,2-Dioxaborolane-4,4-diacetic acid, 2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo-,
1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-,
Ninlaro (TN),
Ixazomib citrate (JAN/USAN),
SCHEMBL4427479,
CHEMBL3545432,
CHEBI:90939,
KS-00000TRH,
MBOMYENWWXQSNW-AWEZNQCLSA-N,
BCP16600,
AKOS030632768,
ZINC200299610,
CS-1720,
SB19502,
2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid,
HY-10452,
FT-0699809,
D10131,
2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoy)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid,
2,2'-{2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid,
2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid,
Ixazomib,
NINLARO,
MLN9708,
MLN 9708,
MLN-9708,
C20-H23-B-Cl2-N2-O9,
1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino] acetyl] amino]-3-methylbutyl]-5-oxo-,
2,2'-{2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-5-oxo-1,3,2- dioxaborolane-4,4-diyl}diacetic acid,